KeyBanc raised the firm’s price target on HealthEquity (HQY) to $125 from $100 and keeps an Overweight rating on the shares.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HQY:
- Morning Movers: Chart Industries, Flowserve both rise following merger pact
- HealthEquity price target raised to $117 from $112 at RBC Capital
- HealthEquity price target raised to $125 from $110 at BofA
- Healthequity’s Strong Financial Performance and Strategic Initiatives Drive Buy Rating
- HealthEquity price target raised to $117 from $110 at Citizens JMP
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue